FDA Classifies Nationwide Eye Drop Recall Due to Sterility Concerns
The U.S. Food and Drug Administration (FDA) has classified a nationwide recall of over 3.1 million bottles of eye drops as a Class II recall, following sterility concerns. The recall, initiated by K.C. Pharmaceuticals, involves a range of over-the-counter eye drop products distributed under various brand names through major retailers like Walgreens, Kroger, and CVS. The FDA's Class II designation indicates that the use of these products may cause temporary or medically reversible adverse health consequences. The recall remains ongoing, with no termination date set, as the FDA continues to assess the situation. 
